Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 27.18 CNY -1.52%
Market Cap: 14.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note

Qingdao Baheal Medical Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Qingdao Baheal Medical Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao Baheal Medical Inc
SZSE:301015
Operating Income
ÂĄ903.5m
CAGR 3-Years
30%
CAGR 5-Years
22%
CAGR 10-Years
N/A
Sinopharm Group Co Ltd
HKEX:1099
Operating Income
ÂĄ20.8B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
11%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Operating Income
ÂĄ8.5B
CAGR 3-Years
-2%
CAGR 5-Years
8%
CAGR 10-Years
10%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Operating Income
ÂĄ4B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
16%
C
China National Medicines Corp Ltd
SSE:600511
Operating Income
ÂĄ2.4B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
18%
Huadong Medicine Co Ltd
SZSE:000963
Operating Income
ÂĄ4.1B
CAGR 3-Years
13%
CAGR 5-Years
4%
CAGR 10-Years
12%
No Stocks Found

Qingdao Baheal Medical Inc
Glance View

Market Cap
14.3B CNY
Industry
Health Care

Qingdao Baheal Medical, Inc. engages in the provision of marketing services for pharmaceutical product manufacturers. The company is headquartered in Qingdao, Shandong and currently employs 2,396 full-time employees. The company went IPO on 2021-06-30. The firm provides brand operation, wholesale distribution and retail services for pharmaceutical products. Its brand operation services include consumer education, product academic promotion, marketing planning, business contacts, product distribution, flow tracking and supply chain management services. The firm's wholesale distribution business mainly centers on Qingdao and Beijing, and radiates second-level and above hospitals, community clinics and pharmacies in surrounding cities. Its wholesale distribution products include medicines, Chinese herbal medicine pieces, medical equipment, diagnostic reagents, medical consumables, among others. The firm mainly conducts its business within domestic market.

Intrinsic Value
45.79 CNY
Undervaluation 41%
Intrinsic Value
Price
Q

See Also

What is Qingdao Baheal Medical Inc's Operating Income?
Operating Income
903.5m CNY

Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Operating Income amounts to 903.5m CNY.

What is Qingdao Baheal Medical Inc's Operating Income growth rate?
Operating Income CAGR 5Y
22%

Over the last year, the Operating Income growth was 24%. The average annual Operating Income growth rates for Qingdao Baheal Medical Inc have been 30% over the past three years , 22% over the past five years .

Back to Top